Newsletter | January 21, 2026

01.21.26 -- Visibility Without Discoverability: A Life Sciences Marketing Challenge

FEATURED ARTICLE

Visibility Without Discoverability: A Life Sciences Marketing Challenge

Life sciences organizations are highly visible and active across established media channels, but discoverability represents an area of untapped potential, writes Daan Inghelram.

INDUSTRY INSIGHTS

Outsourcing Patient Recruitment: What You Need To Know

Sponsors and CROs are increasingly outsourcing patient recruitment to specialized vendors to address the ongoing challenge of meeting initial recruitment targets on time.

Enrollment And Retention: Corporate Meeting Management Best Practices

Discover how a structured, scalable approach to patient support can streamline trial operations, improve retention, and elevate the clinical experience for everyone involved.

Our Approach To Regulatory Compliance In China

Expanding into China’s life sciences market requires strategic alignment and local expertise. Leverage regulatory know-how to turn strict API requirements into a streamlined path to market success.

The Hidden Truths About Prepaid Cards In Clinical Trials

Prepaid debit cards have revolutionized participant payments in clinical trials. However, questions are being raised about transparency and who sets fees.

How Lipid Nanoparticles Enable Next-Gen Delivery

Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.

Nanoformed API: A Superior Alternative To Solid Dispersions

Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.